Liver Disease
📧 Sign up to get email alerts when something new happens for Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-08-28Clinical Trial Update: ¹³C-Methacetin Breath Test (MBT) Methodology Study [Phase 2, Phase 3]
An update on the methodology study of the 13C-Methacetin Breath Test (MBT) for phase 2/phase 3 trials. It involves healthy subjects and pati…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease [NA]
The clinical trial evaluating a relative-dose-response (RDR) test adaptation for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease [Phase 1]
This Phase 1 trial evaluates the pharmacokinetics and safety of neratinib in healthy subjects and in individuals with chronic liver disease …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: TachoSil Paediatric Liver Trial (TC-019-IN) [Phase 3]
Phase 3 pediatric liver trial of TachoSil (TC-019-IN) sponsored by Nycomed has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study comparing hydrocodone extended-release CEP-33237 in subjects with normal hepatic function and those with moder…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients [Phase 2]
A National Institute of Allergy and Infectious Diseases–sponsored Phase 2 trial evaluated immune suppression using alemtuzumab and tacrolimu…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis [Phase 3]
Phase 3 clinical trial update for a breath test (BreathID 13C-Methacetin Breath Test) aimed at detecting cirrhosis in chronic liver disease;…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
This clinical trial update reports on evaluating liver fibrosis staging with Acoustic Radiation Force Impulse elastography in chronic liver …
-
CLINICAL_TRIALS safety_alert · 2011-12-06Clinical Trial Update: Pulmonary Embolism After Liver Resection
The document reports a safety concern regarding pulmonary embolism after liver resection, with related conditions including liver disease an…
-
FDA approval · 2011-11-16FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approves a supplemental application for EOVIST (gadoxetate disodium) from Bayer HealthCare Pharmaceuticals Inc. for its liver-imaging in…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: A Phase II Study of DMP 115 to Assess Focal Liver Lesions [Phase 2]
Phase II study of DMP 115 for focal liver lesions has completed. Sponsor: Lantheus Medical Imaging.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease [Phase 2]
Phase 2 study evaluating PENNEL Capsule for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease [Phase 3]
Phase 3 trial evaluating PENNEL Capsule for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of Naproxcinod in hepatic impairment patients versus healthy subjects; the trial is comp…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: MMF After Pediatric Liver Transplantation [NA]
Clinical trial evaluating mycophenolate mofetil after pediatric liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a as maintenance therapy and its effect on liver disease progression in people co-infect…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of adding ursodeoxycholic acid to a DPP-4 inhibitor in adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Completed pharmacokinetic study evaluating how liver impairment affects dasatinib processing in liver-impaired and healthy subjects. The tri…
-
CLINICAL_TRIALS research · 2011-04-14Clinical Trial Update: Hepatocyte Matrix Implant Study Indonesia [Phase 1]
Phase 1 clinical trial update from Baermed in Indonesia evaluating a hepatocyte matrix implant for liver cirrhosis and hepatic insufficiency…
-
CLINICAL_TRIALS research · 2011-04-12Clinical Trial Update: Hepatocyte Matrix Implant Study [Phase 1]
Phase 1 clinical trial update for a hepatocyte matrix implant in liver disease and liver cirrhosis; the current status of the study is UNKNO…
-
CLINICAL_TRIALS trial_result · 2011-03-03Clinical Trial Update: Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols
A completed clinical trial comparing depletion versus non-depletion immunosuppressive protocols in solid organ transplant recipients, examin…
-
CLINICAL_TRIALS research · 2011-01-28Clinical Trial Update: Volatile Organic Compounds (VOCs) and Liver Diseases
This document provides an update on a clinical trial evaluating volatile organic compounds (VOCs) in relation to liver diseases. The study s…
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding
A clinical trial evaluating allogeneic mesenchymal stem cell transplantation into the liver via the portal vein with ultrasound guidance for…
-
CLINICAL_TRIALS research · 2010-12-08Clinical Trial Update: Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
This clinical trial update describes an intravenous infusion study using allogeneic mesenchymal stem cells in patients with chronic liver di…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures [Phase 3]
Phase 3 trial investigating eltrombopag to reduce platelet transfusions in patients with chronic liver disease and thrombocytopenia undergoi…